|
|
Volumn 328, Issue 7455, 2004, Pages 1513-
|
|
GlaxoSmithKline to publish clinical trials after US lawsuit.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
PAROXETINE;
ADOLESCENT;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CHILD;
CLINICAL TRIAL;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG INDUSTRY;
HUMAN;
INTERNET;
LEGAL APPROACH;
LEGAL ASPECT;
PUBLISHING;
TREATMENT FAILURE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
LEGAL APPROACH;
ADOLESCENT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CHILD;
CLINICAL TRIALS;
DEPRESSIVE DISORDER;
DRUG INDUSTRY;
HUMANS;
INTERNET;
PAROXETINE;
PUBLISHING;
TREATMENT FAILURE;
|
|
EID: 3042796496
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.328.7455.1513-a Document Type: Article |
|
Times cited : (25)
|
|
References (0)
|
